Economics at your fingertips  

Does Funding for HIV and Sexually Transmitted Disease Prevention Matter?

Harrell W. Chesson, Paul Harrison, Carol R. Scotton and Beena Varghese
Additional contact information
Harrell W. Chesson: Centers for Disease Control and Prevention
Paul Harrison: Federal Reserve Board
Carol R. Scotton: Centers for Disease Control and Prevention
Beena Varghese: Centre for Health and Population Research

Evaluation Review, 2005, vol. 29, issue 1, 3-23

Abstract: Since the onset of the AIDS epidemic, the Centers for Disease Control and Prevention (CDC) has allocated several billion dollars for the prevention of HIV and other sexually transmitted diseases (STDs) in the United States. Using state-level data from 1981 to 1998, the authors found that greater amounts of prevention funding in a given year are associated with reductions in reported gonorrhea incidence rates in subsequent years. The authors conclude that funding for STD and HIV prevention, on the whole, appears to have a discernable impact on the incidence of STDs.

Keywords: HIV; sexually transmitted diseases; gonorrhea, Centers for Disease Control and Prevention (search for similar items in EconPapers)
Date: 2005
References: Add references at CitEc
Citations View citations in EconPapers (4) Track citations by RSS feed

Downloads: (external link) (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

More articles in Evaluation Review
Bibliographic data for series maintained by SAGE Publications ().

Page updated 2018-11-17
Handle: RePEc:sae:evarev:v:29:y:2005:i:1:p:3-23